Potential cellular and regenerative approaches for the treatment of Parkinson’s disease
Emma L Lane, Olivia J Handley, Anne E Rosser, Stephen B DunnettBrain Repair Group, School of Biosciences, Cardiff University, CF10 3US, UKAbstract: Parkinson’s disease is most commonly treated with a range of pharmacotherapeutics, with the more recent introduction of surgical technique...
Guardado en:
Autores principales: | Emma L Lane, Olivia J Handley, Anne E Rosser, Stephen B Dunnett |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a79f5795c2314fd9bdecf5715ff4e6b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rasagiline in treatment of Parkinson’s disease
por: Lakshmi Nayak, et al.
Publicado: (2008) -
Sleep disorders in Parkinson’s disease
por: Israt Jahan, et al.
Publicado: (2009) -
Current approaches to the treatment of Parkinson’s disease
por: Joseph Jankovic, et al.
Publicado: (2008) -
Update on ropinirole in the treatment of Parkinson’s disease
por: Holly A Shill, et al.
Publicado: (2008) -
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)